Bertaglia E, Bella PD, Tondo C, Proclemer A, Bottoni N, De Ponti R, et al. Image integration increases efficacy of paroxysmal atrial fibrillation catheter ablation: results from the CartoMerge® Italian Registry.
ThermoCool® Navigation Catheters are approved for recurrent drug/device refractory sustained monomorphic ventricular tachycardia (VT) due to prior myocardial infarction (MI) in adults (excluding ThermoCool® SF Catheters).
The clinical significance of utilizing the PaSo Module to help pace mapping for catheter ablation of ventricular arrhythmias has not been demonstrated by clinical investigations.
The NaviStar® ThermoCool® and EZ Steer® ThermoCool® NAV Catheters are FDA approved for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with compatible three-dimensional electroanatomic mapping systems. Catheter ablation for AF may not be an option for you if you have any of the following conditions: certain recent heart surgery; prosthetic valves; active systemic infection; certain cancers; intracardiac thrombus, or an interatrial baffle or patch. Consult your physician to find out if catheter ablation is right for you.
Known complications of catheter ablation include the following: bleeding, swelling or bruising at the catheter insertion site, and infection. More serious complications are rare, which can include damage to the heart or blood vessels; blood clots (which may lead to stroke); heart attack, or death.
This site last updated on September 4, 2014.